If you’ve come across the latest dietary guidelines, a few things may have caught your attention: a big ol’ steak front and center in the new “inverted pyramid”, beef tallow and butter recommended as “healthy” fats, a declaration that the war on protein is ending. “Since when have we been at war with protein?” you may reasonably ask. In part 2 of our episodes on dietary guidelines, we get to the bottom of the latest iteration of these guidelines and investigate which changes are good (there are a few), which are bad (definitely a few there), and which are somewhere in between. Then we explore what science has actually shown about what constitutes a “healthy” diet. Tune in for a lively discussion that features lots of complaining about protein-enriched products, exasperated sighs, and a few shocking revelations about “the American diet.”

Support this podcast by shopping our latest sponsor deals and promotions at this link: https://bit.ly/3WwtIAu

See omnystudio.com/listener for privacy information.

Over the decades, dietary guidelines have taken a diverse array of shapes, from pamphlets to wheels, from plates to pyramids. In many cases, the shapes have changed more than the recommendations they contain. This week and next, we explore those recommendations - who’s making them, how they have changed over time, and how closely they align with what we should be eating. First, we delve into the long history of dietary guidelines and how their intentions have evolved as the food landscape drastically changed over the 20th century. Then we interrogate the conflicts of interests at the heart of their formation, questioning how much these recommendations are backed by science vs industry interests. Ultimately, we come back to the question of “if few people actually use these guidelines, why should we care about them at all?” Turns out, we have lots of feelings on the matter.

Support this podcast by shopping our latest sponsor deals and promotions at this link: https://bit.ly/3WwtIAu

See omnystudio.com/listener for privacy information.

Why do we believe what we believe? Is what we believe the truth? How can we convince others of our beliefs? If you’ve ever found yourself pondering these questions, you know that the answers are rarely clear-cut. We need to form beliefs in order to navigate the world, but how skilled are we at evaluating evidence for those beliefs or weighing new data that contradicts them? In this week’s TPWKY book club episode, Adam Kucharski, Professor at the London School of Hygiene and Tropical Medicine joins me to discuss latest book, Proof: The Art and Science of Certainty. With this book, Dr. Kucharski presents a compelling and thoughtful examination of the concept of proof, delving into topics ranging from the justice system (what’s a reasonable doubt?) to infectious disease, clinical design to the founding of this country. And he leaves us with a powerful lesson: what convinced you of something might not convince someone else. Tune in for a fascinating conversation!

Support this podcast by shopping our latest sponsor deals and promotions at this link: https://bit.ly/3WwtIAu

See omnystudio.com/listener for privacy information.

Tear gas is an expected, normalized part of protests today. But its use in international war is banned. How can that be? That’s just one of the questions we investigate in this episode. First, we take you through the long history of tear gas and its emergence alongside deadlier chemical weapons before discussing how its use became routine, fueled by industry interests. Then we delve into what’s in tear gas that causes the painful physical reaction and consider whether claims of non-toxicity are backed up by research (spoilers: not really). This is an info-packed episode that will leave you with many questions answered, but not all of those answers will be satisfying.

Support this podcast by shopping our latest sponsor deals and promotions at this link: https://bit.ly/3WwtIAu

See omnystudio.com/listener for privacy information.

Though discovered relatively recently, Oropouche virus has been making headlines as an emerging vector-borne infectious disease on the rise. Not transmitted by the usual suspects (like ticks and mosquitoes), this virus is instead spread through the bites of midges or no-see-ums. Since these arthropods are already widely distributed and their range is growing thanks to climate change, this is a recipe for potential disaster. In this episode, we take you through the story of Oropouche virus, from how it makes us sick to what the construction of a highway has to do with its discovery, from surprising prevalence statistics to the history of One Health. Tune in for the full scoop on this midge and the virus it carries.

Support this podcast by shopping our latest sponsor deals and promotions at this link: https://bit.ly/3WwtIAu

See omnystudio.com/listener for privacy information.

For the entirety of our species’ history, our approach to cancer has largely been to react, to design new therapies and better combinations of treatments. This energy has certainly been well-spent, but what if we didn’t have to use treatment at all? Or what if we could minimize the use of aggressive therapies? Prevention and screening represent two under-appreciated pillars of cancer care, and we’re using this final installment in our cancer miniseries to show some appreciation. To grasp the impact that screening and prevention can have, we also need to consider the global landscape of cancer prevalence and incidence - where is it decreasing? Where is it on the rise? Where can intervention or prevention make an impact? As we’ve shown over these four episodes, science and medicine has accumulated a wealth of information about cancer - but the striking racial and socioeconomic disparities in cancer incidence and mortality in the US and around the world demonstrates that that knowledge has not been applied equally. Any proposal to reduce the global cancer burden must address the systemic issues driving these disparities. Tune in for a thought-provoking reflection on the status of cancer today.

Support this podcast by shopping our latest sponsor deals and promotions at this link: https://bit.ly/3WwtIAu

See omnystudio.com/listener for privacy information.

A century and a half ago, the list of effective cancer treatments was essentially a single entry: surgery. Today, in 2026, you’d need pages to contain the number of treatments available, and multiple notebooks to delineate all of the various therapies currently in development. It is nothing short of a revolution. Of course, no revolution is perfect, and many cancer treatments are ineffective or carry risks of serious side effects. In part 3 of our cancer series, we delve into all facets of cancer treatment, from the history of their development to how they actually work. Tune in to learn how far we’ve come and where we might go from here in our perennial quest to treat and cure cancer.

Support this podcast by shopping our latest sponsor deals and promotions at this link: https://bit.ly/3WwtIAu

See omnystudio.com/listener for privacy information.

For centuries, physicians noticed that cancer sometimes ran in families, but until the 1960s, an answer to this mystery remained out of reach. Only then were scientists beginning to unlock the cellular dynamics underlying cancer, and what they found finally allowed grief-stricken families to put a name and explanation to their experience. It wasn’t simply bad luck. It was genetics: a heritable mutation in a key tumor suppressor gene that greatly increases the risk of developing cancer in your lifetime, a condition known as Li-Fraumeni Syndrome. Journalist Lawrence Ingrassia belongs to one of those families; he has lost his mother, three siblings, and a nephew to cancer. In this TPWKY book club episode, Ingrassia joins me to discuss his book A Fatal Inheritance: How a Family Misfortune Revealed a Deadly Medical Mystery, where he weaves together his family’s story with that of the scientists who sought to uncover the cellular drivers of cancer. Tune in for a heartbreaking and inspiring journey.

Support this podcast by shopping our latest sponsor deals and promotions at this link: https://bit.ly/3WwtIAu

See omnystudio.com/listener for privacy information.

Each of our cells can become cancerous. It’s an uncomfortable, yet unavoidable truth. Nor is it a truth restricted to our species - cancer is a consequence of complex life. The features that make a cell cancerous are those that, under other circumstances, are beneficial, essential even, for an individual’s growth and survival. How is that possible? In the second installment in our series, we’re putting cancer under the microscope to consider the qualities that underlie a cancer cell’s success in our body. By placing cancer in an evolutionary framework, we can not only understand why cancer is so darn prevalent, but we can also leverage that knowledge to devise new approaches to treatment - working with evolution rather than against it. If you’ve ever wondered why we haven’t come up with a cure for all cancer or why some animals get cancer more than others, this is the episode for you.

Support this podcast by shopping our latest sponsor deals and promotions at this link: https://bit.ly/3WwtIAu

See omnystudio.com/listener for privacy information.

Cancer has touched every one of us in some capacity, and learning of a diagnosis inspires many more questions than it answers. In this four-part series on cancer, we aim to lay a foundation of knowledge that will help make sense of this multifaceted disease. We begin our four-part series on cancer by asking a deceptively simple question: what is cancer? As we’ll discover over the course of these episodes, there is not one answer but many. After all, cancer is not one disease but many. In this first episode, we examine the clinical definitions of cancer - when someone receives a cancer diagnosis, how is that determined, and what does that mean? Viewing that question through a historical lens reveals our changing understanding of cancer and how that knowledge filters into the public perception of this disease. With cancer diagnoses on the rise, it’s tempting to label cancer a disease of the 20th or 21st centuries. But is that the case? Tune in to find out.

Support this podcast by shopping our latest sponsor deals and promotions at this link: https://bit.ly/3WwtIAu

See omnystudio.com/listener for privacy information.